Exo-Target® Exosome based Therapeutics
Exo-Target® is the therapeutic exosomes loaded with API molecule(‘target’ molecule) via ILIAS’s various platform technologies. Exo-Target® enables targeted delivery of API into the target cells by utilizing natural tropism of exosome producing cells and tissue targeting moieties displayed on the surface of exosome.
With our proprietary technology, ILIAS Biologics developed scalable exosome production system for Exo-Target® with high yield and purity
- Cell Line Development We are working on variety of cell types to develop exosome producing cell bank in the perspective of high productivity, stability and target tissue·cell tropism.
- In-vivo Study For safe and effective exosome therapeutics development, ILIAS Biologics conducts preclinical animal study either in our in-house animal facility or with our research collaborators who have relevant preclinical animal model in their laboratory.
- Scientific Analysis ILIAS science team is continuously working on exosome analysis method development for the characterization and quality control of our exosome therapeutics, Exo-Target®.
- Large Scale Manufacturing We successfully establish a large scale exosome production line in ILIAS Innovation Center, which allows us to produce Exo-Target® with the highest consistency in the yield and purity of exosome.